{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-26-000074","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2026-11-10T21:30:20+00:00","discovered_at":"2026-11-10T21:32:00.204626+00:00","generated_at":"2026-11-10T21:32:30.173507+00:00","sec_items":["7.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elevance Health reaffirms 2026 EPS guidance of at least $22.00 and adjusted EPS of at least $29.00","bullets":["Elevance Health reaffirmed full-year 2026 shareholders' earnings guidance of at least $22.00 per diluted share.","Guidance includes approximately $7.00 per diluted share of net unfavorable items; adjusted earnings guidance is at least $29.00.","The company reaffirmed 2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points.","Officers expect to speak with investors and analysts this week and cited no other adjustment items beyond Q3 2026 earnings."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-26-000074","json":"https://secwatch.observer/filing/0001156039-26-000074.json","markdown":"https://secwatch.observer/filing/0001156039-26-000074.md","text":"https://secwatch.observer/filing/0001156039-26-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/0001156039-26-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/elv-20261110.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T21:32:30.173507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}